6IN - Synthetic lethality - EZH2 inhibitor tazemetostat in INI1-negative tumors

Date 05 March 2018
Event TAT 2018 - Targeted Anticancer Therapies
Session Novel epigenetic targets
Presenter Antoine Italiano
Authors A. Italiano
  • Early Phase Trials Unit, Institute Bergonié, 33076 - Bordeaux/FR